Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML

Relapse remains the major cause of mortality for patients with Acute Myeloid Leukemia (AML). Improved tracking of minimal residual disease (MRD) holds the promise of timely treatment adjustments to preempt relapse. Current surveillance techniques detect circulating blasts that coincide with advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Hornick, Noah I., Huan, Jianya, Doron, Ben, Goloviznina, Natalya A., Lapidus, Jodi, Chang, Bill H., Kurre, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650871/
https://www.ncbi.nlm.nih.gov/pubmed/26067326
http://dx.doi.org/10.1038/srep11295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650871/
https://www.ncbi.nlm.nih.gov/pubmed/26067326
http://dx.doi.org/10.1038/srep11295

Ejemplares similares